HIV News and Research

RSS

Africa must develop its own pharmaceutical pipeline through creation of policy frameworks

"To break free of its dependence on donor money and supplies from India, Africa must develop its own pharmaceutical pipeline by creating policy frameworks that encourage a fledgling drug industry," journalist Priya Shetty argues in this SciDev.Net opinion piece.

23 Mar 2012

Blog posts comment on World TB Day

Several blog posts recently commented on the upcoming World Tuberculosis (TB) Day, commemorated on March 24. "Despite a clear legislative mandate, the U.S. Global Health Initiative (GHI) has consistently failed to live up to the goals of" the Tom Lantos and Henry J. Hyde United States Leadership Against HIV/AIDS, Tuberculosis (TB), and Malaria Reauthorization Act, passed by Congress in 2008, John Fawcett, legislative director for RESULTS, writes in the Center for Global Health Policy's "Science Speaks" blog.

23 Mar 2012

Research roundup: Unequal 'culture of quality' in hospitals; Peer-support for stressed doctors

Comparison Of Hospital Performance In Trauma Vs Emergency And Elective General Surgery –This study compared outcomes of trauma patients and patients having either elective or emergency surgery in the same hospital. Researchers thought that "hospital performance reflected institutional culture, and, thus, would be similar across all services."

23 Mar 2012

NGOs release joint statement calling for governments to increase payments to Global Fund to fill gap in TB funding

Ahead of World Tuberculosis (TB) Day on March 24, three non-governmental organizations (NGOs) released a joint statement warning that "[a] $1.7 billion funding shortfall to fight [TB] over the next five years means 3.4 million patients will go untreated and gains made against the disease will be reversed," Reuters reports.

23 Mar 2012

Human Immunity to Tuberculosis conference to take place from April 13-14

Leading international experts in tuberculosis and related diseases from at least 10 countries will gather at a Human Immunity to Tuberculosis conference April 13-14 in Atlanta. The meeting will take place at the Emory Conference Center, 1615 Clifton Rd., Atlanta, GA 30329.

23 Mar 2012

UI receives three grants to hasten discovery of new TB therapeutics

Forty-five years. That's how long it's been since the last drug - rifampin - hit the market to treat tuberculosis, an infection that affects nearly one third of the world's population and causes 1.8 million deaths annually. The University of Illinois at Chicago College of Pharmacy has received three new federally-funded grants to hasten the discovery of new therapeutic treatments.

23 Mar 2012

Emergent receives NIAID grant to advance development of MVA85A TB vaccine

Emergent BioSolutions Inc. today announced that it has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to advance the development of MVA85A, a candidate vaccine against tuberculosis.

23 Mar 2012

Experts discuss significant findings from CROI in video interview

This post in the AIDS.gov blog provides video of Ron Valdiserri, deputy assistant secretary of health for infectious diseases, interviewing Jonathan Mermin, director of the CDC Division of HIV/AIDS Prevention, at the recent 19th Conference on Retroviruses and Opportunistic Infections.

22 Mar 2012

New method for in vivo study of unknown selenium metabolism

Spanish and Danish researchers have developed a method for the in vivo study of the unknown metabolism of selenium, an essential element for living beings. The technique can help clarify whether or not it possesses the anti-tumour properties that have been attributed to it and yet have not been verified through clinical trials.

22 Mar 2012

Cannabinoid drugs can directly inhibit HIV in late-stage AIDS

Mount Sinai School of Medicine researchers have discovered that marijuana-like chemicals trigger receptors on human immune cells that can directly inhibit a type of human immunodeficiency virus (HIV) found in late-stage AIDS, according to new findings published online in the journal PLoS ONE.

21 Mar 2012

China's Ministry of Health reports about 900,000 cases of active TB in 2011

"About 900,000 cases of active tuberculosis (TB) were discovered and treated in China in 2011, including 423,000 infectious cases, the Ministry of Health (MOH) announced Monday at a press conference," Xinhua reports.

21 Mar 2012

GeoVax enters into definitive agreements to sell Series A convertible preferred stock

GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.

21 Mar 2012

New vaccine strategy to advance solutions for tuberculosis

Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis , the strategic blueprint for the TB vaccine field, represents consensus reached by the TB vaccine community.

20 Mar 2012

Indian patent court licenses generic copy of Bayer’s blockbuster anticancer drug

Last week an Indian patent court shocked the $600 billion global pharmaceutical business by ordering Bayer, the German health care giant, to allow a tiny Indian generic drug company to sell cheap copies of the blockbuster cancer drug Nexavar – even though everyone agrees that the drug is protected by a patent. Instead, the court decided that Bayer had an obligation to make Nexavar available to people in India who needed it.

20 Mar 2012

Chemists produce first high resolution structure of HCV viral RNA-inhibitor complex

Chemists at the University of California, San Diego have produced the first high resolution structure of a molecule that when attached to the genetic material of the hepatitis C virus prevents it from reproducing.

20 Mar 2012

World Bank report calls for increased HIV prevention efforts in Africa

In a report published last week, the World Bank "called on African governments and international donors to increase efforts to prevent new HIV infections in order to control treatment costs," VOA News reports.

20 Mar 2012

CSIS report examines HIV prevention, care among people who inject drugs in Ukraine

A new report, titled "Injection Drug Use in Ukraine" and published by the Center for Strategic & International Studies (CSIS), examines the challenges of providing HIV prevention and care services in the country, particularly to people who inject drugs (PWID), who accounted for "nearly 50 percent of new HIV infections registered in 2010," according to the CSIS website.

20 Mar 2012

Tyler Prize for Environmental Achievement honors two experts on air pollution

Tyler Prize for Environmental Achievement honors two experts on air pollution with the 2012 Tyler Prize for their work to advance the scientific understanding of air pollution, and develop solutions to reduce the danger to human health and the impact on climate change.

20 Mar 2012

Study identifies new hypervariable regions in human gut viruses

A growing body of evidence underscores the importance of human gut bacteria in modulating human health, metabolism, and disease. Yet bacteria are only part of the story. Viruses that infect those bacteria also shape who we are. Frederic D. Bushman, PhD, professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania, led a study published this month in the Proceedings of the National Academy of Sciences that sequenced the DNA of viruses -- the virome -- present in the gut of healthy people.

20 Mar 2012

AIDS survey preliminary data show stagnation in Uganda's HIV prevalence, need for improved prevention strategies, experts say

A preliminary report on the Uganda AIDS Indicator Survey, conducted by the Ministry of Health, shows the country's "HIV prevalence rate has stagnated over the last 10 years, and the number of people infected with HIV has risen from 1.8 million people to 2.3 million today," the Observer writes.

20 Mar 2012

HIV News and Research

Africa must develop its own pharmaceutical pipeline through creation of policy frameworks

Blog posts comment on World TB Day

Research roundup: Unequal 'culture of quality' in hospitals; Peer-support for stressed doctors

NGOs release joint statement calling for governments to increase payments to Global Fund to fill gap in TB funding

Human Immunity to Tuberculosis conference to take place from April 13-14

UI receives three grants to hasten discovery of new TB therapeutics

Emergent receives NIAID grant to advance development of MVA85A TB vaccine

Experts discuss significant findings from CROI in video interview

New method for in vivo study of unknown selenium metabolism

Cannabinoid drugs can directly inhibit HIV in late-stage AIDS

China's Ministry of Health reports about 900,000 cases of active TB in 2011

GeoVax enters into definitive agreements to sell Series A convertible preferred stock

New vaccine strategy to advance solutions for tuberculosis

Indian patent court licenses generic copy of Bayer’s blockbuster anticancer drug

Chemists produce first high resolution structure of HCV viral RNA-inhibitor complex

World Bank report calls for increased HIV prevention efforts in Africa

CSIS report examines HIV prevention, care among people who inject drugs in Ukraine

Tyler Prize for Environmental Achievement honors two experts on air pollution

Study identifies new hypervariable regions in human gut viruses

AIDS survey preliminary data show stagnation in Uganda's HIV prevalence, need for improved prevention strategies, experts say

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News